Abstract:
Disclosed are compounds of formula (I): wherein R3, R5, R7 and R8 are defined herein, which are useful as inhibitors SYK kinase and are thus useful for treating diseases resulting from inappropriate mast cell activation, which include allergic and inflammatory diseases. Also disclosed are pharmaceutical compositions comprising these compounds and processes for preparing these compounds.
Abstract:
A system and method facilitating document image compression utilizing a mask separating a foreground of a document image from a background is provided. The invention includes a pixel energy analyzer adapted to partition regions into a foreground and background. The invention further provides for a merge region component adapted to attempt to merge regions if the merged region would not exceed a threshold energy. Merged regions are partitioned into a new foreground and new background. Thereafter, a mask storage component stores the partitioning information in a binary mask.
Abstract:
The present invention relates to a method of automatically processing an electronic document for routing over a computer network. The method includes recognizing text in the document to identify a candidate address, accessing a collection of potential destinations and comparing the candidate address to the collection of potential destinations to determine a destination for the document.
Abstract:
Quinazolines of the formula I in which R, R1, R2, R3, R4 and Y have the meaning indicated in Patent Claim 1, and their salts or solvates as glycoprotein IbIX antagonists.
Abstract:
Systems and methods for encoding and decoding document images are disclosed. Document images are segmented into multiple layers according to a mask. The multiple layers are non-binary. The respective layers can then be processed and compressed separately in order to achieve better compression of the document image overall. A mask is generated from a document image. The mask is generated so as to reduce an estimate of compression for the combined size of the mask and multiple layers of the document image. The mask is then employed to segment the document image into the multiple layers. The mask determines or allocates pixels of the document image into respective layers. The mask and the multiple layers are processed and encoded separately so as to improve compression of the document image overall and to improve the speed of so doing. The multiple layers are non-binary images and can, for example, comprise a foreground image and a background image.
Abstract:
A global optimization framework for optical character recognition (OCR) of low-resolution photographed documents that combines a binarization-type process, segmentation, and recognition into a single process. The framework includes a machine learning approach trained on a large amount of data. A convolutional neural network can be employed to compute a classification function at multiple positions and take grey-level input which eliminates binarization. The framework utilizes preprocessing, layout analysis, character recognition, and word recognition to output high recognition rates. The framework also employs dynamic programming and language models to arrive at the desired output.
Abstract:
Disclosed are compounds of formula (I): wherein R3, R5, R7 and R8 are defined herein, which are useful as inhibitors SYK kinase and are thus useful for treating diseases resulting from inappropriate mast cell activation, which include allergic and inflammatory diseases. Also disclosed are pharmaceutical compositions comprising these compounds and processes for preparing these compounds.
Abstract:
Disclosed are compounds of formula (I): wherein R3, R5, R7 and R8 are defined herein, which are useful as inhibitors SYK kinase and are thus useful for treating diseases resulting from inappropriate mast cell activation, which include allergic and inflammatory diseases. Also disclosed are pharmaceutical compositions comprising these compounds and processes for preparing these compounds.
Abstract:
Disclosed are compounds of formula (I): wherein R3, R5, R7 and R8 are defined herein, which are useful as inhibitors SYK kinase and are thus useful for treating diseases resulting from inappropriate mast cell activation, which include allergic and inflammatory diseases. Also disclosed are pharmaceutical compositions comprising these compounds and processes for preparing these compounds.
Abstract:
Quinazolinones of formula (I) in which R, R1, R2, R3, R4, Y, n and m have the meaning indicated in Patent claim 1, and their salts or solvates as glycoprotein IbIX antagonists